Operating Lease, Right-of-Use Asset in USD of AbCellera Biologics Inc. from Q4 2022 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
AbCellera Biologics Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2022 to Q3 2025.
  • AbCellera Biologics Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2025 was $138M, a 102% increase year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)

AbCellera Biologics Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $138M +$69.6M +102% Sep 30, 2025 10-Q 2025-11-06
Q2 2025 $137M +$66.8M +95.2% Jun 30, 2025 10-Q 2025-08-07
Q1 2025 $68.7M -$2.59M -3.63% Mar 31, 2025 10-Q 2025-05-08
Q4 2024 $66.6M -$6.49M -8.88% Dec 31, 2024 10-Q 2025-11-06
Q3 2024 $68.3M Sep 30, 2024 10-Q 2024-11-04
Q2 2024 $70.2M Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $71.3M Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $73.1M -$7.7M -9.52% Dec 31, 2023 10-K 2025-02-27
Q4 2022 $80.8M Dec 31, 2022 10-K 2024-02-20
* An asterisk sign (*) next to the value indicates that the value is likely invalid.